List of Tables
Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of HSV-based Oncolytic Viruses
Table 3. Key Players of Adenoviruses-based Oncolytic Viruses
Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses
Table 5. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table 6. Key Players of Newcastle Disease Virus-based Oncolytic Viruses
Table 7. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Oncolytic Virus Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Oncolytic Virus Therapy Market Size by Region (US$ Million), 2021–2026
Table 10. Global Oncolytic Virus Therapy Market Share by Region (2021–2026)
Table 11. Global Oncolytic Virus Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Oncolytic Virus Therapy Market Share by Region (2027–2032)
Table 13. Oncolytic Virus Therapy Market Trends
Table 14. Oncolytic Virus Therapy Market Drivers
Table 15. Oncolytic Virus Therapy Market Challenges
Table 16. Oncolytic Virus Therapy Market Restraints
Table 17. Global Oncolytic Virus Therapy Revenue by Players (US$ Million), 2021–2026
Table 18. Global Oncolytic Virus Therapy Market Share by Players (2021–2026)
Table 19. Global Top Oncolytic Virus Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oncolytic Virus Therapy Revenue, 2025
Table 20. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Oncolytic Virus Therapy, Headquarters and Area Served
Table 23. Global Key Players of Oncolytic Virus Therapy, Products and Applications
Table 24. Global Key Players of Oncolytic Virus Therapy, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Oncolytic Virus Therapy Market Size by Type (US$ Million), 2021–2026
Table 27. Global Oncolytic Virus Therapy Revenue Market Share by Type (2021–2026)
Table 28. Global Oncolytic Virus Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Oncolytic Virus Therapy Revenue Market Share by Type (2027–2032)
Table 30. Global Oncolytic Virus Therapy Market Size by Application (US$ Million), 2021–2026
Table 31. Global Oncolytic Virus Therapy Revenue Market Share by Application (2021–2026)
Table 32. Global Oncolytic Virus Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Oncolytic Virus Therapy Revenue Market Share by Application (2027–2032)
Table 34. North America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Oncolytic Virus Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. North America Oncolytic Virus Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Oncolytic Virus Therapy Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Oncolytic Virus Therapy Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Oncolytic Virus Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Oncolytic Virus Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (US$ Million), 2027–2032
Table 49. Amgen Company Details
Table 50. Amgen Business Overview
Table 51. Amgen Oncolytic Virus Therapy Product
Table 52. Amgen Revenue in Oncolytic Virus Therapy Business (US$ Million), 2021–2026
Table 53. Amgen Recent Development
Table 54. RIGVIR Group Company Details
Table 55. RIGVIR Group Business Overview
Table 56. RIGVIR Group Oncolytic Virus Therapy Product
Table 57. RIGVIR Group Revenue in Oncolytic Virus Therapy Business (US$ Million), 2021–2026
Table 58. RIGVIR Group Recent Development
Table 59. 3s-guojian Company Details
Table 60. 3s-guojian Business Overview
Table 61. 3s-guojian Oncolytic Virus Therapy Product
Table 62. 3s-guojian Revenue in Oncolytic Virus Therapy Business (US$ Million), 2021–2026
Table 63. 3s-guojian Recent Development
Table 64. Shuanghe Pharmaceutical Company Details
Table 65. Shuanghe Pharmaceutical Business Overview
Table 66. Shuanghe Pharmaceutical Oncolytic Virus Therapy Product
Table 67. Shuanghe Pharmaceutical Revenue in Oncolytic Virus Therapy Business (US$ Million), 2021–2026
Table 68. Shuanghe Pharmaceutical Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
Table 72. Authors List of This Report
List of Figures
Figure 1. Oncolytic Virus Therapy Picture
Figure 2. Global Oncolytic Virus Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Oncolytic Virus Therapy Market Share by Type: 2025 vs 2032
Figure 4. HSV-based Oncolytic Viruses Features
Figure 5. Adenoviruses-based Oncolytic Viruses Features
Figure 6. Vaccinia Virus-based Oncolytic Viruses Features
Figure 7. Vesicular Stomatitis Virus-based Oncolytic Viruses Features
Figure 8. Newcastle Disease Virus-based Oncolytic Viruses Features
Figure 9. Global Oncolytic Virus Therapy Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Oncolytic Virus Therapy Market Share by Application: 2025 vs 2032
Figure 11. Melanoma Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Breast Cancer Case Studies
Figure 14. Ovarian Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Oncolytic Virus Therapy Report Years Considered
Figure 17. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 18. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Oncolytic Virus Therapy Market Share by Region: 2025 vs 2032
Figure 20. Global Oncolytic Virus Therapy Market Share by Players in 2025
Figure 21. Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2025
Figure 23. North America Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. North America Oncolytic Virus Therapy Market Share by Country (2021–2032)
Figure 25. United States Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Canada Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Oncolytic Virus Therapy Market Share by Country (2021–2032)
Figure 29. Germany Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. France Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. U.K. Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Italy Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Russia Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Ireland Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Oncolytic Virus Therapy Market Share by Region (2021–2032)
Figure 37. China Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Japan Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. South Korea Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Southeast Asia Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. India Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Australia & New Zealand Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Oncolytic Virus Therapy Market Share by Country (2021–2032)
Figure 45. Mexico Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Brazil Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2021–2032)
Figure 49. Israel Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Saudi Arabia Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. UAE Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2021–2026)
Figure 53. RIGVIR Group Revenue Growth Rate in Oncolytic Virus Therapy Business (2021–2026)
Figure 54. 3s-guojian Revenue Growth Rate in Oncolytic Virus Therapy Business (2021–2026)
Figure 55. Shuanghe Pharmaceutical Revenue Growth Rate in Oncolytic Virus Therapy Business (2021–2026)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
